Clinical trials
Phase 1/2 Retinal Degeneration trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beacon Therapeutics | 2 |
| AsclepiX Therapeutics, Inc. | 1 |
| BlueRock Therapeutics | 1 |
| David M. Brown, M.D. | 1 |
| Editas Medicine, Inc. | 1 |
| Elisigen, Inc. | 1 |
| GenSight Biologics | 1 |
| Gyroscope Therapeutics Limited | 1 |
| National Eye Institute (NEI) | 1 |
| Opus Genetics, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Degeneration | 14 |
| Retinal Diseases | 8 |
| Eye Diseases | 6 |
| Macular Degeneration | 4 |
| Cone-Rod Dystrophies | 3 |
| Eye Diseases, Hereditary | 3 |
| Retinal Dystrophies | 3 |
| Retinitis Pigmentosa | 3 |
| Choroidal Neovascularization | 2 |
| Anetoderma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.